These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 4022347)

  • 1. Cerebral blood flow and cognitive impairment in Parkinson's disease.
    Globus M; Mildworf B; Melamed E
    Neurology; 1985 Aug; 35(8):1135-9. PubMed ID: 4022347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regional cerebral blood flow in patients with Parkinson's disease.
    Lavy S; Melamed E; Cooper G; Bentin S; Rinot Y
    Arch Neurol; 1979 Jun; 36(6):344-8. PubMed ID: 454231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive function and regional cerebral blood flow in Parkinson's disease.
    Jagust WJ; Reed BR; Martin EM; Eberling JL; Nelson-Abbott RA
    Brain; 1992 Apr; 115 ( Pt 2)():521-37. PubMed ID: 1606480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regional cerebral blood flow in Parkinson's disease as an indicator of cognitive impairment.
    Derejko M; Sławek J; Wieczorek D; Brockhuis B; Dubaniewicz M; Lass P
    Nucl Med Commun; 2006 Dec; 27(12):945-51. PubMed ID: 17088679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive functions in Parkinson's disease: relation to disease severity and hallucination.
    Wakamori T; Agari T; Yasuhara T; Kameda M; Kondo A; Shinko A; Sasada S; Sasaki T; Furuta T; Date I
    Parkinsonism Relat Disord; 2014 Apr; 20(4):415-20. PubMed ID: 24467818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of nicergoline treatment in Parkinson's disease associated with dementia.
    Lee S; Na SH; Chung YA; Jeong H; Song IU
    J Clin Neurosci; 2019 Dec; 70():136-139. PubMed ID: 31431403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Motor and cognitive function in Lewy body dementia: comparison with Alzheimer's and Parkinson's diseases.
    Gnanalingham KK; Byrne EJ; Thornton A; Sambrook MA; Bannister P
    J Neurol Neurosurg Psychiatry; 1997 Mar; 62(3):243-52. PubMed ID: 9069479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive and SPECT characteristics predict progression of Parkinson's disease in newly diagnosed patients.
    Dujardin K; Defebvre L; Duhamel A; Lecouffe P; Rogelet P; Steinling M; Destée A
    J Neurol; 2004 Nov; 251(11):1383-92. PubMed ID: 15592735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Occipital hypoperfusion in Parkinson's disease without dementia: correlation to impaired cortical visual processing.
    Abe Y; Kachi T; Kato T; Arahata Y; Yamada T; Washimi Y; Iwai K; Ito K; Yanagisawa N; Sobue G
    J Neurol Neurosurg Psychiatry; 2003 Apr; 74(4):419-22. PubMed ID: 12640053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical evaluation of Parkinson's disease using 123I-IMP SPECT].
    Hayashi H; Odano I; Nishihara M; Higuchi S; Sakai K; Ishikawa A
    Kaku Igaku; 1989 Nov; 26(11):1405-15. PubMed ID: 2615027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intellectual impairment in Parkinson's disease--correlation with cerebral cortical blood flow.
    Yoshii F; Saitoh H; Takizawa S; Shinohara Y
    Tokai J Exp Clin Med; 1986 Nov; 11(5):361-9. PubMed ID: 3672565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between depression and regional cerebral blood flow in Parkinson's disease and the effect of selegiline treatment.
    Imamura K; Okayasu N; Nagatsu T
    Acta Neurol Scand; 2011 Jul; 124(1):28-39. PubMed ID: 20880269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Posterior cortical brain dysfunction in cognitively impaired patients with Parkinson's disease--a rCBF scintigraphy study.
    Wallin A; Ekberg S; Lind K; Milos V; Granérus AK; Granerus G
    Acta Neurol Scand; 2007 Dec; 116(6):347-54. PubMed ID: 17927803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Analysis of cognitive function and regional cerebral blood flow in Parkinson's disease by 123I-IMP SPECT].
    Yamamoto K
    Rinsho Shinkeigaku; 1992 Jan; 32(1):1-7. PubMed ID: 1628430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in regional cerebral blood flow caused by deep-brain stimulation of the subthalamic nucleus in Parkinson's disease.
    Sestini S; Scotto di Luzio A; Ammannati F; De Cristofaro MT; Passeri A; Martini S; Pupi A
    J Nucl Med; 2002 Jun; 43(6):725-32. PubMed ID: 12050315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regional cerebral blood flow in parkinsonism. Measurement before and after levodopa.
    Melamed E; Lavy S; Cooper G; Bentin S
    J Neurol Sci; 1978 Oct; 38(3):391-7. PubMed ID: 731264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Correlation of the cognitive function and the duration of the illness with the regional cerebral blood flow in the patients with Parkinson's disease: objective evaluation using stereotactic extraction estimation analysis in 123I-IMP SPECT].
    Sakai T; Kuzuhara S
    No To Shinkei; 2006 Jan; 58(1):29-37. PubMed ID: 16482919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristic clinical aspects of Parkinson patients with intellectual impairment.
    Piccirilli M; Piccinin GL; Agostini L
    Eur Neurol; 1984; 23(1):44-50. PubMed ID: 6714277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropsychological and psychiatric differences between Alzheimer's disease and Parkinson's disease with dementia.
    Starkstein SE; Sabe L; Petracca G; Chemerinski E; Kuzis G; Merello M; Leiguarda R
    J Neurol Neurosurg Psychiatry; 1996 Oct; 61(4):381-7. PubMed ID: 8890777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [An analysis of regional cerebral blood flows (rCBF) in 120 patients with cerebrovascular disease].
    Shang MQ
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1991 Feb; 24(1):30-2, 62. PubMed ID: 1868765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.